Vaccination has long been a cornerstone of public health—but recent updates to U.S. immunization guidelines have sparked renewed conversation among providers, parents, and patients. One of the goals of the Energize and Revitalize Podcast is to help listeners understand both the science and the evolving dialogue around healthcare decisions. Here’s a breakdown of what’s changed, what hasn’t, and the perspectives shaping the conversation today.
What Has Changed in the New Guidelines
Recent updates from the U.S. Department of Health and Human Services (HHS) and CDC have introduced several notable shifts:
1. Fewer Routine Vaccines Recommended
- The number of diseases covered by routine childhood vaccines has been reduced from 17 to 11
- Routine vaccines decreased from 13 to 7
- Some vaccines (like influenza, hepatitis A & B, and COVID-19) are now:
- No longer universally recommended
- Instead categorized under “shared clinical decision-making“
This means decisions are now more individualized between provider and patient/parent.
2. Shift Toward Personalized Decision-Making
Rather than a one-size-fits-all schedule, there is increased emphasis on:
- Individual risk factors
- Patient preferences
- Provider guidance
3. Push for More Rigorous Research
There is a growing call for:
- More placebo-controlled trials
- Long-term safety data
This reflects a broader effort to rebuild trust and increase transparency in public health.
What Has NOT Changed
Despite the updates, several key principles remain consistent:
1. Vaccines Are Still a Core Public Health Tool
Mainstream medical organizations continue to emphasize that vaccines:
- Prevent serious infectious diseases
- Have played a major role in reducing illness and death
2. Many Vaccines Still Strongly Recommended
Vaccines for diseases like:
- Measles
- Polio
- Whooping cough
remain standard recommendations due to their proven effectiveness and risk reduction.
3. Safety Monitoring Continues
Vaccines continue to undergo:
- Clinical trials
- Ongoing surveillance for safety
Many existing vaccines were studied extensively, though not always against a placebo in every iteration—particularly when an effective vaccine already existed.
A Clinical Conversation: Insights from Our Podcast
In a recent episode of Energize and Revitalize with Dr. Amy, I spoke with pharmacists Dr. Sylvia Boblak and Dr. James Boblak about their perspective on vaccines and immune health. They shared a viewpoint that is part of a broader ongoing conversation:
- Vaccines often contain adjuvants (ingredients designed to stimulate the immune system)
- Their perspective is that repeated stimulation of the immune system may influence how the body responds over time
- They also expressed concern that many vaccines are not always compared to inert placebos, especially when prior versions already exist
- There is further concern about the rise in autoimmune conditions and the possibility that vaccine administration is increasing the risk
This perspective reflects questions that some practitioners and patients are asking as they seek a deeper understanding of long-term immune health.
How This Compares to Mainstream Medical Perspective
Most public health organizations and vaccine advocates emphasize:
- Adjuvants are safe and are used specifically to enhance immune response
- Large studies have not shown an increase in serious adverse outcomes from these ingredients
- Placebo-controlled trials are not always used when it would be unethical to withhold an already proven effective vaccine
They also caution that:
- Lower vaccination rates could lead to resurgence of preventable diseases
- Public confidence in vaccines plays a critical role in community health
My Opinion
I think vaccines have increased the quality of our lives by preventing devastating diseases. I read about the history of diseases like Polio and their long-term debilitating effects. My generation never had to worry about that. As a healthcare provider, I’m thankful to be vaccinated against Hepatitis B. However, we may have taken some vaccines too far. Do we need to be vaccinated against less debilitating diseases? Do we need to give as many vaccines early in life?
When I was the primary care practitioner at the health department. Some new parents would ask if they could give the vaccines more slowly. “Of course,” I said. “Let’s talk about priorities.” I would always recommend the polio vaccine. We do not want to see polio return to this country. However, if a mother was negative for Hepatitis B (we test for this during pregnancy), then the chance of that baby contracting Hepatitis B is almost none. That decision can be made later.
My children received the standard recommended immunizations. My daughter was vaccinated against HPV as a pre-teen. My son was not. My husband and I chose not to get the COVID-19 vaccine and we did not give it to our son (our other children were adults by this time). When people asked me why, I explained that I am not anti-vax. However, in this case, I don’t feel this particular vaccine was studied for long enough. This vaccine and its controversies deserve a separate discussion and a podcast episode as well.
Why This Conversation Matters
What we’re seeing right now is a shift from: Standardized protocols → More individualized care and discussion. This creates:
- More opportunity for patient education
- More responsibility for providers to guide nuanced conversations
- More need for patients to be informed and engaged
The Bottom Line
The new immunization guidelines don’t eliminate vaccines—but they do signal a shift toward:
- Personalization
- Transparency
- Ongoing evaluation of data
At the same time, there remains strong support within the medical community for vaccines as a key tool in preventing disease. Healthcare is not one-size-fits-all—and understanding both the science and the conversation allows you to make the best choices for yourself and your family. Let’s keep talking. Check out the full interview with Dr. Sylvia Boblak and Dr. James Boblak.